SEC Form 4 · accession 0001209191-16-105765
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank H Valone M.D.
Officer — Chief Medical Officer
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2016 | M | 6,528 | $3.925 | A | 115,133 | D | |
| Common Stock | Mar 1, 2016 | M | 2,508 | $2.90 | A | 117,641 | D | |
| Common Stock | Mar 1, 2016 | M | 1,714 | $3.50 | A | 119,355 | D | |
| Common StockF1,F2 | Mar 1, 2016 | S | 7,260 | $16.471 | D | 112,095 | D | |
| Common StockF1,F3 | Mar 1, 2016 | S | 3,490 | $17.6106 | D | 108,605 | D | |
| Common Stock | holding | — | — | — | 4,000 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $3.925 | Mar 1, 2016 | M | 6,528 | D | — | Aug 11, 2019 | Common Stock | 6,528 | 13,472 | D |
| Stock Option (Right to Buy)F4 | $2.90 | Mar 1, 2016 | M | 2,508 | D | — | Jun 9, 2020 | Common Stock | 2,508 | 5,000 | D |
| Stock Option (Right to Buy)F4 | $3.50 | Mar 1, 2016 | M | 1,714 | D | — | Jun 7, 2021 | Common Stock | 1,714 | 30,028 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2The shares were sold at prices between $16.02 and $17.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares were sold at prices between $17.02 and $17.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Fully vested.